Grassi Investment Management Abb Vie Inc. Transaction History

Grassi Investment Management

$1.13 Billion
Q2 2024

A detailed history of Grassi Investment Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Grassi Investment Management holds 101,500 shares of ABBV stock, worth $19.6 Million. This represents 1.54% of its overall portfolio holdings.

Number of Shares

101,500

Previous 102,250 0.73%

Holding current value

$19.6 Million

Previous $18.6 Million 6.5%

% of portfolio

1.54%

Previous 1.68%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 09, 2024	SELL	$154.79 - $180.76 $116,092 - $135,570	-750 Reduced 0.73%	101,500 $17.4 Million
Q1 2024 Apr 10, 2024	SELL	$159.82 - $182.1 $63,928 - $72,840	-400 Reduced 0.39%	102,250 $18.6 Million
Q3 2023 Oct 11, 2023	SELL	$133.59 - $154.65 $6,679 - $7,732	-50 Reduced 0.05%	102,650 $15.3 Million
Q2 2023 Jul 11, 2023	SELL	$132.51 - $164.9 $13,251 - $16,490	-100 Reduced 0.1%	102,700 $13.8 Million
Q1 2023 Apr 11, 2023	SELL	$144.61 - $166.54 $169,916 - $195,684	-1,175 Reduced 1.13%	102,800 $16.4 Million
Q2 2022 Jul 12, 2022	SELL	$137.62 - $174.96 $199,549 - $253,692	-1,450 Reduced 1.38%	103,975 $15.9 Million
Q1 2022 Apr 12, 2022	SELL	$131.98 - $163.75 $52,791 - $65,500	-400 Reduced 0.38%	105,425 $17.1 Million
Q4 2021 Jan 13, 2022	SELL	$107.43 - $135.93 $42,972 - $54,372	-400 Reduced 0.38%	105,825 $14.3 Million
Q3 2021 Oct 12, 2021	BUY	$106.4 - $120.78 $236,740 - $268,735	2,225 Added 2.14%	106,225 $11.5 Million
Q2 2021 Jul 09, 2021	SELL	$105.21 - $117.21 $23,672 - $26,372	-225 Reduced 0.22%	104,000 $11.7 Million
Q1 2021 Apr 12, 2021	BUY	$102.3 - $112.62 $150,892 - $166,114	1,475 Added 1.44%	104,225 $11.3 Million
Q4 2020 Jan 19, 2021	BUY	$80.49 - $108.67 $1.44 Million - $1.95 Million	17,910 Added 21.11%	102,750 $11 Million
Q3 2020 Oct 13, 2020	BUY	$85.91 - $100.83 $583,328 - $684,635	6,790 Added 8.7%	84,840 $7.43 Million
Q2 2020 Jul 15, 2020	BUY	$73.37 - $98.18 $40,353 - $53,999	550 Added 0.71%	78,050 $7.66 Million
Q1 2020 Apr 08, 2020	BUY	$64.5 - $97.79 $38,700 - $58,674	600 Added 0.78%	77,500 $5.91 Million
Q3 2019 Oct 04, 2019	SELL	$62.98 - $75.72 $18,894 - $22,716	-300 Reduced 0.39%	76,900 $5.82 Million
Q2 2019 Jul 10, 2019	SELL	$65.7 - $83.98 $22,995 - $29,393	-350 Reduced 0.45%	77,200 $5.61 Million
Q1 2019 Apr 10, 2019	SELL	$77.14 - $90.79 $4.31 Million - $5.07 Million	-55,885 Reduced 41.88%	77,550 $6.25 Million
Q4 2018 Jan 10, 2019	SELL	$77.85 - $96.01 $105,642 - $130,285	-1,357 Reduced 1.01%	133,435 $12.3 Million
Q3 2018 Oct 12, 2018	SELL	$88.91 - $98.84 $30,940 - $34,396	-348 Reduced 0.26%	134,792 $12.7 Million
Q2 2018 Jul 10, 2018	SELL	$89.78 - $106.23 $37,258 - $44,085	-415 Reduced 0.31%	135,140 $12.5 Million
Q1 2018 Apr 10, 2018	SELL	$92.01 - $123.21 $142,523 - $190,852	-1,549 Reduced 1.13%	135,555 $12.8 Million
Q4 2017 Jan 10, 2018	BUY	$89.56 - $98.21 $116,517 - $127,771	1,301 Added 0.96%	137,104 $13.3 Million
Q3 2017 Oct 10, 2017	BUY	$69.85 - $89.22 $9.49 Million - $12.1 Million	135,803	135,803 $12.1 Million

Others Institutions Holding ABBV

# of Institutions

3,689

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $342B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grassi Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Grassi Investment Management with notifications on news.

Account

Grassi Investment Management Abb Vie Inc. Transaction History